Ipsen Will Build center in Massachusetts | Chemical & Engineering News
Volume 90 Issue 1 | p. 12 | Concentrates
Issue Date: January 2, 2012

Ipsen Will Build center in Massachusetts

Department: Business
Keywords: R&D, drug discovery, employment

The French drug company Ipsen will invest $45 million to expand its R&D center in Milford, Mass. The site’s current staff of 150 includes chemists, biologists, and translational science experts working on the firm’s peptide and toxin R&D platforms. A new building, set to open in 2014, will house R&D and process science centers that support Ipsen’s goal of delivering five new molecular entities and three drug proofs of concept by 2015.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment